Research and Markets: The Global Peptic Ulcer Therapeutics Market Is Forecast To Grow At A CAGR Of 2% to $1,046.2m By 2018 – Boston Globe

The peptic ulcer market is well served by Proton Pump Inhibitors (PPIs), which form the majority. PPIs include omeprazole, lansoprazole, pantoprazole, Nexium (esomeprazole) and Aciphex (rabeprazole); and histamine blockers such as ranitidine …